HHsearch alignment for GI: 254780777 and conserved domain: TIGR00761

>TIGR00761 argB acetylglutamate kinase; InterPro: IPR004662 N -Acetylglutamate (NAG) fulfils distinct biological roles in lower and higher organisms. In prokaryotes, lower eukaryotes and plants it is the first intermediate in the biosynthesis of arginine, whereas in ureotelic (excreting nitrogen mostly in the form of urea) vertebrates, it is an essential allosteric cofactor for carbamyl phosphate synthetase I (CPSI), the first enzyme of the urea cycle. The pathway that leads from glutamate to arginine in lower organisms employs eight steps, starting with the acetylation of glutamate to form NAG. In these species, NAG can be produced by two enzymatic reactions: one catalysed by NAG synthase (NAGS) and the other by ornithine acetyltransferase (OAT). In ureotelic species, NAG is produced exclusively by NAGS. In lower organisms, NAGS is feedback-inhibited by L-arginine, whereas mammalian NAGS activity is significantly enhanced by this amino acid. The NAGS genes of bacteria, fungi and mammals are more diverse than other arginine-biosynthesis and urea-cycle genes. The evolutionary relationship between the distinctly different roles of NAG and its metabolism in lower and higher organisms remains to be determined . The pathway from glutamate to arginine is: NAGS; N-acetylglutamate synthase (2.3.1.1 from EC) (glutamate to N-acetylglutamate) NAGK; N-acetylglutamate kinase (2.7.2.8 from EC) (N-acetylglutamate to N-acetylglutamate-5P) NAGSA; N-acetyl-gamma-glutamyl-phosphate reductase (1.2.1.38 from EC) (N-acetylglutamate-5P to N-acetylglumate semialdehyde) Acetylornithine aminotransferase (2.6.1.11 from EC) (N-acetylglumate semialdehyde to N-acetylornithine) Acetylornithine deacetylase (3.5.1.16 from EC) (N-acetylornithine to ornithine) Arginase (3.5.3.1 from EC) (ornithine to arginine) This entry describes N-acetylglutamate kinases (ArgB) of many prokaryotes and the N-acetylglutamate kinase domains of multifunctional proteins from yeasts as well as some, as yet, uncharacterised proteins.; GO: 0003991 acetylglutamate kinase activity, 0006526 arginine biosynthetic process, 0005737 cytoplasm.
Probab=99.61  E-value=1.1e-14  Score=110.05  Aligned_cols=199  Identities=18%  Similarity=0.231  Sum_probs=123.6

Q ss_pred             EEEEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCE-EEEEECCCCCHHHH-H----HHC--CCC-----CCCCHHH
Q ss_conf             999940036853887770899999999999999976990-99982365410233-4----420--377-----7754024
Q gi|254780777|r    9 VLLKVSGEALAGISGFGVDIDSVNRICADIAEVYAKGIE-IGIVVGGGNIFRGS-Q----VVA--ENY-----LLCERST   75 (242)
Q Consensus         9 IViKiGGSsL~~~~~~~~~~~~i~~ia~~I~~~~~~g~~-vviV~sg~~~~~~~-~----~~~--~~~-----~~~~~~~   75 (242)
T Consensus         2 ~ViK~GG~~~~~~-------~~~~~~~~~~~~l~~~g~~PpviVHGGGp~in~~~~~lgi~~~f~~Gl~G~~~RvTd~~t   74 (254)
T TIGR00761         2 IVIKIGGSAISND-------ELLEEFFSDIAFLRAVGIKPPVIVHGGGPEINELLEALGIEPEFKNGLSGVVFRVTDKET   74 (254)
T ss_pred             EEEEECCEEECCC-------HHHHHHHHHHHHHHHCCCCCCEEEECCCHHHHHHHHHCCCCCEEECCCCCEEEECCCHHH
T ss_conf             7898447341041-------246999999999997298553898378526888998328983676688720375278899


Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHH------------HHH--------------HHHHHHHHHCCHHHHC
Q ss_conf             67888889899999999999761886411340010------------024--------------5665432100001100
Q gi|254780777|r   76 VDSMGMLSTVINALALDLALRKINVPTVILSSIFM------------PQV--------------CEVFSCRNAVSYLSQG  129 (242)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~--------------~~~~~~~~~~~~~~~~  129 (242)
T Consensus        75 l~v~~~vL~g~vN~~LV~~l~~~g~~A~GL~g~Dg~L~~a~rk~~~~~~~~~~vv~~~~G~VG~~~~Vn~~~~~~Ll~~G  154 (254)
T TIGR00761        75 LEVVEMVLIGDVNKELVALLNKHGINAIGLTGLDGQLFTADRKTASLDKEVIKVVAIDLGYVGEIKKVNKALLEALLKAG  154 (254)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEEEEEEEEEEECCCEEEEEECCCEEEECCCCHHHHHHHHHCC
T ss_conf             99989998364669999999967992863113577357999878988515768999974841231327889999999649


Q ss_pred             CCCCCCCCC------CCCCCCCHHHHHHHHHHHCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCH-HHHHH-------C
Q ss_conf             111112465------567776215788888641644665147543512343223444444441159-99985-------5
Q gi|254780777|r  130 KVVIFSGGT------GNAFLTTDSAAALRASEIGADVILKGTQVDGVYSADPRVHASSTRFDSLTY-NQFIE-------K  195 (242)
Q Consensus       130 ~~~~~~~~~------~~~~~~~D~~a~~ia~~~~ad~l~i~tdvdGiyt~dP~~~~~ak~i~~is~-~e~l~-------~  195 (242)
T Consensus       155 ~~PVi~sla~~~~~g~~lNvNAD~aA~~lA~~L~A~kL~~LtDv~Gi~~~y~---d~~~~i~~l~~D~~~~~l~~~~~i~  231 (254)
T TIGR00761       155 IIPVIASLALTNAEGQALNVNADTAAGELAAALGAEKLVLLTDVPGILNGYP---DKQSLISELPLDEEIEQLIKQGVIK  231 (254)
T ss_pred             CCCEECCCCCCHHCCCEEECCHHHHHHHHHHHCCCCEEEEECCCHHHHCCCC---CCCCEECCCCHHHHHHHHHHHHHHC
T ss_conf             8517716658623187770677799999998609953888417403225888---7461402268679999877522231


Q ss_pred             CCCCCCHHHHHHHHHCCCCEEE
Q ss_conf             9981409999999974996999
Q gi|254780777|r  196 GLKVMDCASVVLARDCSIPIIV  217 (242)
Q Consensus       196 G~~v~~~~A~~~a~~~gI~v~I  217 (242)
T Consensus       232 gGMipKV~~a~~A~~~Gv~~v~  253 (254)
T TIGR00761       232 GGMIPKVNAALEALESGVKSVI  253 (254)
T ss_pred             CCCHHHHHHHHHHHHCCCCEEC
T ss_conf             5985789999999973888003